Function of tetrandrine in preparing liver scathing-prevention medicament

A technology of tetrandrine and liver injury, applied in the field of pharmacy
CN101199529AInactive Publication Date: 2008-06-18SHANGHAI INST OF BIOLOGICAL SCI CHINESE ACAD OF SCI +1

Patent Information

Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
SHANGHAI INST OF BIOLOGICAL SCI CHINESE ACAD OF SCI
Publication Date
2008-06-18
Estimated Expiration
Not applicable · inactive patent

Smart Images

  • Figure 1
    Figure 1
  • Figure 2
    Figure 2
  • Figure 3
    Figure 3
Patent Text Reader

Abstract

The invention discloses an application of tetrandrine, which is used to prepare combined substances for inhibiting the expressions of chemokines and to control liver injury. The invention firstly discovers the new application of the tetrandrine in controlling hepatitis or liver injury. The invention has strong pharmacological effects without side effect , and thus the invention has good prospect in medicine. Furthermore, the tetrandrine can be directly extracted from the plants and is convenient to be taken with advantages of low toxicity, rich source, low price and simple preparation process.
Need to check novelty before this filing date? Find Prior Art

Description

technical field

[0001] The invention belongs to the field of pharmacy, and specifically relates to the use of tetrandrine in the preparation of medicines for preventing and treating hepatitis and liver damage. Background technique

[0002] Hepatitis is a major disease that seriously endangers human health. From the perspective of etiology, hepatitis is mainly divided into: viral hepatitis, alcoholic hepatitis, autoimmune hepatitis and so on. The incidence of hepatitis, especially viral hepatitis, in China continues to be relatively high. As far as hepatitis B is concerned, there are 2 billion people infected with hepatitis B virus in the world, of which 690 million are in China, and the hepatitis B virus surface antigen (HBsAg) is carried around the world. There are 350 million people affected by hepatitis B virus, one-third of which are in China; 750,000 people die from diseases caused by hepatitis B virus infection every year in the world, of which 280,000 people are from ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More